ClinicalTrials.gov
public full text
Public Domain
Durvalumab and Tremelimumab Combination in Somatically Hypermutated Recurrent Solid Tumors
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Preoperative prediction of tumor budding grade in rectal cancer by combining APT histogram analysis and ADC MRI.#218889
- Immunogenic cell death inducers and PD-1 blockade as neoadjuvant therapy for rectal cancer#1146223
- Trientine and Carboplatin in Advanced Malignancies#896182
- Preoporative Bevacizumab, Radiation Therapy, and XELOX Chemotherapy for Locally Advanced Nonmetastatic Rectal Cancer#812160
- The role of microRNAs-23b and 27b in migration, invasion and proliferation of T24 bladder cancer cells.#1097973
Record · ID 249599
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive